Benefits of adjuvant chemo for soft tissue sarcoma patients

Share :
Published: 10 Oct 2016
Views: 2470
Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy

Dr Gronchi speaks with ecancertv at ESMO 2016 about the responses of patients with advanced soft tissue sarcoma to adjuvant epirubicin plus ifosfamide compared to those receiving a tailored chemo regimen based on histology subgrouping

He reports significantly improved relapse-free survival and overall survival for patients receiving adjuvant chemo, thought notes the trial is a technical failure due to being powered for the histology-tailored sub types which did not show any benefit.

Dr Gronchi presented these results to the conference, with video available here, and the story is reported in ecancer news here.